MolNFT v1 · #128612 · protein
PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2- (cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4- methylthiazol-5-YL)BENZYL)PYRROLIDINE-2-carboxamide (ligand 18)
5NW1 · Elongin-B: “PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2- (cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4…”. X-ray diffraction, 1 ligand (9BH), 8 pockets (best druggability 0.61). MolNFT v1 #128612 on GenesisL1: 3D…
- PDB
- 5NW1
- Type
- protein
- Length
- 1,338 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Elongin-B; Elongin-C; Von hippel-lindau disease tumor suppressor
- UniProt
- Q15370, Q15369, P40337
- Ligands
- 9BH
- Pockets
- 8 · best druggability 0.61
Structure
x-ray diffraction · 8 distinct chains · 32% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Elongin-B | protein | 104 | 17% helix, 38% strand | Q15370 |
| B | Elongin-C | protein | 87 | 48% helix, 15% strand | Q15369 |
| C | Von hippel-lindau disease tumor suppressor | protein | 141 | 24% helix, 30% strand | P40337 |
| D, G, J | Elongin-B | protein | 103 | 15% helix, 39% strand | Q15370 |
| E | Elongin-C | protein | 91 | 46% helix, 14% strand | Q15369 |
| F, I, L | Von hippel-lindau disease tumor suppressor | protein | 143 | 27% helix, 29% strand | P40337 |
| H | Elongin-C | protein | 89 | 43% helix, 15% strand | Q15369 |
| K | Elongin-C | protein | 88 | 44% helix, 15% strand | Q15369 |
Ligands and binding sites
- 9BH · (2~{S},4~{R})-1-[(2~{S})-2-(cyclobutylcarbonylamino)-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · 4 copies · chains C, L, F, I
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 287 | 0.61 | 0.79 | 43 | 9BH |
| 2 | 258 | 0.61 | 0.80 | 37 | 9BH |
| 3 | 173 | 0.49 | 0.77 | 30 | empty |
| 4 | 165 | 0.46 | 0.76 | 26 | empty |
| 5 | 145 | 0.45 | 0.76 | 27 | empty |
Interfaces
19 interfaces between chains.
- J–K · 1148 Ų buried · 12 hydrogen bonds · protein-protein
- G–H · 1132 Ų buried · 12 hydrogen bonds · protein-protein
- D–E · 1127 Ų buried · 12 hydrogen bonds · protein-protein
- A–B · 1124 Ų buried · 12 hydrogen bonds · protein-protein
- B–C · 1068 Ų buried · 12 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 12 modified (artifact).
Compared structures
- 5NW1 · pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutan… · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 5NW1 · PDBe 5NW1 · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.